Kapoose Creek Bio, a biotechnology company leveraging AI for drug discovery from nature, has acquired an exclusive license to Adapsyn Bioscience’s chemical informatics platform, and acquired its drug discovery lab and talent.   The agreement with Adapsyn, a Canadian company backed by Genesys Capital and other private investors, offers Kapoose Creek Bio an opportunity to accelerate its growth, and further populate its development pipeline.   Adapsyn’s informatics technologies comp...